Thank you for your comprehensive report of the meeting in Memphis. But even if I am very bullish for the medium and long term, I do not see everything as bright as some do (taking the risk getting blamed as a "shorty").
1100 prescriptions on a daily or even weekly basis would be really good news to investors, but if this is the total amount of prescriptions for the (nearly) complete US-market since introduction, it does not sound that big to me.
A CFO that is buying the stock is a positive sign to me, too. But only if the investment has a significant character. Sorry, but USD 5'000 is not a big deal, and the risk of being wrong is very limited. This looks more like a goody to me for the shareholder's mood, but a real investment based on the assumption of investing in a bargain (if I would know, that my company's stock is undervalued, I would take the risk and invest more - my opinion).
The third thing that makes me wonder, if everything is as brilliant as we see it, why is the stock coming down further on. Are we few the only one who are seeing the truth, and all the others who sell the stock are blind?
Don't get me wrong, as I mentioned before I do own the stock, I am adding and I do (for the moment) not thinking of selling. But we should not see everything through pink glasses, only because we want the stock go up again.
Good day,
Richard |
